Zhenshao Zhong

Title: Zhenshao Zhong: Innovator in Autoantibody Positive Disease Treatment

Introduction

Zhenshao Zhong is a notable inventor based in Potomac, MD, who has made significant contributions to the field of medical treatment for autoantibody positive diseases. His innovative work focuses on developing methods and compositions that aim to improve patient outcomes in this challenging area of healthcare.

Latest Patents

Zhenshao Zhong holds a patent for "Methods and compositions for use in treatment of patients with autoantibody positive disease." This invention relates to methods for treating patients with specific autoantibody profiles, particularly those with systemic lupus erythematosus. The patent outlines a method of administering an immunomodulatory agent, such as an antagonist of Neutrokine-alpha, to patients exhibiting an ANA titer of 1:80 or greater and/or elevated levels of anti-dsDNA antibodies. Additionally, the invention provides methods for reducing corticosteroid administration frequency in these patients.

Career Highlights

Zhenshao Zhong is associated with Human Genome Sciences, Inc., where he has been instrumental in advancing research and development in the field of immunology. His work has contributed to a better understanding of autoantibody positive diseases and has the potential to improve treatment protocols for affected patients.

Collaborations

Zhenshao Zhong has collaborated with notable colleagues, including Marc Chevrier and William W. Freimuth, to further enhance the research and development efforts at Human Genome Sciences, Inc. Their combined expertise has fostered innovation in the treatment of complex autoimmune conditions.

Conclusion

Zhenshao Zhong's contributions to the treatment of autoantibody positive diseases highlight his role as a key innovator in the medical field. His patented methods and collaborations with esteemed colleagues underscore the importance of continued research in improving patient care.